On Feb 1, 2022 Phylos closed a Venture – Series Unknown round and raised $7,600,000 from Accomplice, Entourage Effect Capital, Merida Capital Holdings, featuring lead […]
Post-IPO Debt – Centogene
On Feb 1, 2022 Centogene closed a Post-IPO Debt round and raised $45,000,000 from Oxford Finance LLC, featuring lead investors Oxford Finance LLC. About the […]
Post-IPO Equity – Centogene
On Feb 1, 2022 Centogene closed a Post-IPO Equity round and raised €15,000,000 from Careventures, DPE Deutsche Private Equity, TVM Capital Life Science, featuring lead […]
Series B – Simcha Therapeutics
On Jan 27, 2022 Simcha Therapeutics closed a Series B round and raised $40,000,000 from ArrowMark Partners, BVF Partners, Logos Capital, Rock Springs Capital, Samsara […]
Post-IPO Debt – Trinity Biotech
On Jan 27, 2022 Trinity Biotech closed a Post-IPO Debt round and raised $81,250,000 from investors, featuring lead investors . About the company: Trinity Biotech […]
Series A – Septerna
On Jan 27, 2022 Septerna closed a Series A round and raised $100,000,000 from BVF Partners, Casdin Capital, Catalio Capital Management, Invus, Logos Capital, Samsara […]
Post-IPO Equity – Vaccinex
On Jan 27, 2022 Vaccinex closed a Post-IPO Equity round and raised $6,600,000 from Albert Friedberg, Jacob Frieberg, Maurice Zauderer, featuring lead investors . About […]
Series A – Kula Bio
On Jan 27, 2022 Kula Bio closed a Series A round and raised $50,000,000 from BOPU, Collaborative Fund, Embark Ventures, iSELECT FUND, Lowercarbon Capital, Neglected […]
Series A – TenSixteen Bio
On Jan 27, 2022 TenSixteen Bio closed a Series A round and raised $40,000,000 from Foresite Capital, GV, featuring lead investors Foresite Capital, GV. About […]
Post-IPO Equity – Vaccinex
On Jan 27, 2022 Vaccinex closed a Post-IPO Equity round and raised $6,600,000 from Albert Friedberg, Jacob Frieberg, Maurice Zauderer, featuring lead investors . About […]
